# Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Study · id `cardio:ct-nct05119179` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05119179](<https://clinicaltrials.gov/study/NCT05119179>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05119179

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT05119179. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-22 (actual); primary completion 2026-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT05119179, source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)
- Started: 2021-11-22 (actual) (ClinicalTrials.gov record NCT05119179, source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)
- Primary completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT05119179, source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)
- Completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT05119179, source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05119179, source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05119179-2026-03-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- Condition: PreDiabetes
- Intervention (Drug): Semaglutide
- Lead sponsor: The University of Texas Health Science Center, Houston
- Lead sponsor class: OTHER
- Collaborator: Vanderbilt University Medical Center
- Collaborator class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry intervention name matches this record: Semaglutide (`cardio:semaglutide`)
- Registry intervention is a member of this class by a sourced record link: GLP-1 receptor agonists (drug class) (`cardio:glp1-receptor-agonists`)
- Registry lists this organization as the lead sponsor: The University of Texas Health Science Center, Houston (`cardio:org-the-university-of-texas-health-science-center-houston`)
- Registry lists this organization as a collaborator: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: 440dd68db77d9e4a77b674f31a75c52731e95ecc56244e50414685c7ec85d1ea
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
